DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 1 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,410,135 | +2.8% | 196,425 | 0.0% | 0.74% | +79.1% |
| Q2 2023 | $2,345,315 | -10.7% | 196,425 | 0.0% | 0.41% | -24.1% |
| Q1 2023 | $2,626,202 | -37.9% | 196,425 | 0.0% | 0.54% | -40.3% |
| Q4 2022 | $4,227,066 | +7.4% | 196,425 | 0.0% | 0.91% | -0.8% |
| Q3 2022 | $3,934,000 | +11.9% | 196,425 | 0.0% | 0.92% | -2.1% |
| Q2 2022 | $3,516,000 | +75.0% | 196,425 | -3.0% | 0.94% | +85.2% |
| Q1 2022 | $2,009,000 | -41.1% | 202,500 | 0.0% | 0.51% | -23.6% |
| Q4 2021 | $3,412,000 | -29.0% | 202,500 | 0.0% | 0.66% | -12.2% |
| Q3 2021 | $4,805,000 | +4.2% | 202,500 | 0.0% | 0.75% | +32.5% |
| Q2 2021 | $4,611,000 | – | 202,500 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30,571,453 | 26.81% |
| Atlas Venture Life Science Advisors, LLC | 7,608,394 | $93,354,994 | 14.46% |
| DAFNA Capital Management LLC | 586,463 | $7,195,901 | 2.24% |
| Nicholas Investment Partners, LP | 2,188,654 | $26,854,785 | 2.01% |
| RA Capital Management | 7,809,852 | $95,826,884 | 1.89% |
| BRAIDWELL LP | 3,715,573 | $45,590,081 | 1.44% |
| PFM Health Sciences, LP | 2,224,598 | $27,295,817 | 1.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 530,000 | $6,503,100 | 1.18% |
| COMMODORE CAPITAL LP | 739,661 | $9,075,640 | 1.06% |
| Parkman Healthcare Partners LLC | 466,408 | $5,722,826 | 1.05% |